Alzheimer disease

Feasibility and Acceptability of Implementing a Digital Cognitive Assessment for Alzheimer Disease and Related Dementias in Primary Care
Nicole R. Fowler, Dustin B. Hammers, Anthony J. Perkins, Diana Summanwar, Anna Higbie, Kristen Swartzell, Jared R. Brosch and Deanna R. Willis

The Annals of Family Medicine April 2025, 240293; DOI: https://doi.org/10.1370/afm.240293
Feasibility and Acceptability of the “About Me” Care Card as a Tool for Engaging Older Adults in Conversations About Cognitive Impairment
Stuart W. Grande, Mikele Epperly, Karynn Yee-Huey Tan, Supriya Yagnik, Michael Ellenbogen, Jane Pederson, Alberto Villarejo-Galende, Rae Lynn Ziegler and Greg Kotzbauer

The Annals of Family Medicine March 2025, 23 (2) 117-126; DOI: https://doi.org/10.1370/afm.240165
Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis
Mark H. Ebell, Henry C. Barry, Kanishka Baduni and Gabrielle Grasso

The Annals of Family Medicine January 2024, 22 (1) 50-62; DOI: https://doi.org/10.1370/afm.3050
Prognosis of Mild Cognitive Impairment in General Practice: Results of the German AgeCoDe Study
Hanna Kaduszkiewicz, Marion Eisele, Birgitt Wiese, Jana Prokein, Melanie Luppa, Tobias Luck, Frank Jessen, Horst Bickel, Edelgard Mösch, Michael Pentzek, Angela Fuchs, Sandra Eifflaender-Gorfer, Siegfried Weyerer, Hans-Helmut König, Christian Brettschneider, Hendrik van den Bussche, Wolfgang Maier, Martin Scherer, Steffi G. Riedel-Heller and The Study on Aging, Cognition, and Dementia in Primary Care Patients (AgeCoDe) Study Group

The Annals of Family Medicine March 2014, 12 (2) 158-165; DOI: https://doi.org/10.1370/afm.1596

Main menu

User menu

Search

Alzheimer disease

Content

Info for

Engage

About